1. United States
2. Calif.
3. Letter

This legislation seeks to prohibit the FDA from approving new abortion drugs, restrict the use of previously approved abortion medications, and impose stringent regulations on their administration. However, such measures undermine individuals' reproductive rights and bodily autonomy. If the genuine goal is to support maternal and infant health, more comprehensive approaches would be more effective. Universal healthcare access could significantly improve prenatal care, address pregnancy complications, and provide better postnatal support for mothers and babies. Robust sexual education and contraceptive access empower family planning. Maintaining legal options for reproductive healthcare, including abortion when needed, is crucial for women's health and lives. Pursuing a solely restrictive agenda neglects these holistic solutions. Furthermore, this federal legislation contradicts stated principles of allowing states to determine abortion policies after overturning Roe v. Wade. A consistent approach would leave such decisions to state jurisdictions rather than imposing national mandates. I urge reconsideration of this bill and a shift towards policies that comprehensively support maternal and child well-being through expanded healthcare access and individual rights over one's own reproductive choices.